OBLN Obalon Therapeutics Inc.

$3.45

43,032 Shares Traded
56,139 Average Volume (last 30 days)

as of April 18, 2018 EST IEX Real-Time Price

Free Newsletter Sign Up

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $0
If Intiated on the First, Shorts Have Realized a Year to Date Return of:51.75%
If Intiated One Month Ago, Shorts Have Realized a Return of:8.97%
If Initiated Five Days ago, Shorts Have Realized a Return of:0%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 4.16%
Short Interest697.93 thousand
Float16.77 million
Short Ratio8.39
Market Cap$60.76 million
Market Maker ActivityDaily Short Volume

News

04-12-2018
April 16th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Obalon Therapeutics, Inc. (OBLN) (Business Wire)
04-12-2018
Scott+Scott, Attorneys at Law, LLP Reminds Investors of Securities Class Action Against Obalon Therapeutics, Inc. (OBLN) and April 16 Lead Plaintiff Deadline (PR Newswire)
04-11-2018
OBLN INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Obalon Therapeutics, Inc. Investors (Business Wire)
04-10-2018
Glancy Prongay & Murray LLP Reminds Investors of the April 16, 2018 Deadline in the Class Action Lawsuit Against Obalon Therapeutics, Inc. (OBLN) (Business Wire)
04-09-2018
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Obalon Therapeutics, Inc. (OBLN) and Encourages Investors to Contact the Firm Before April 16th (Business Wire)
04-07-2018
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Obalon Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - OBLN (Business Wire)
03-28-2018
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Obalon Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - OBLN (Business Wire)
03-27-2018
OBALON THERAPEUTICS LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Obalon Therapeutics, Inc. To Contact The Firm (Business Wire)
03-22-2018
OBLN NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Obalon Therapeutics, Inc. - OBLN (PR Newswire)
03-16-2018
DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Obalon Therapeutics, Inc. to Contact the Firm (Business Wire)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 46%
Insider Percent4.8%

Earnings Stats

PE Ratio -1.66
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $7.17
50 Day Moving Average $3.85
52 Week High $13.18
52 Week Low $3.17



Data provided for free by IEX. Questions? Read the FAQ